Surgery-Induced Cachexia Prevention Systems for Specialized Environments

Publication ID: 24-11857525_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Surgery-Induced Cachexia Prevention Systems for Specialized Environments,” Published Technical Disclosure No. 24-11857525_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857525_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,525.

Summary of the Inventive Concept

The present disclosure relates to novel, specialized systems and methods for preventing surgery-induced cachexia in patients undergoing high-risk surgeries, particularly in extreme weather conditions, disaster relief situations, or for patients with compromised immune systems.

Background and Problem Solved

The original patent disclosed compositions and methods for treating or preventing surgery-induced cachexia and/or expression of myeloid-derived suppressor cells and pro-inflammatory cytokines. However, these compositions and methods may not be suitable for patients undergoing high-risk surgeries or in unique operational environments. The present inventive concept addresses these limitations by providing specialized systems and methods tailored to these specific needs.

Detailed Description of the Inventive Concept

The inventive concept encompasses four main embodiments: 1) a system for treating or preventing surgery-induced cachexia in patients undergoing radical cystoprostatectomy, comprising a specialized immunonutrition supplement specifically formulated for bladder cancer patients; 2) a method for preventing cachexia in patients undergoing surgery in extreme weather conditions, comprising administering a composition packaged in a portable, waterproof container; 3) a kit for treating cachexia in disaster relief situations, comprising a specialized immunonutrition supplement, a water purification system, and instructions for administering the supplement to patients in need; and 4) a system for preventing cachexia in patients undergoing high-risk surgeries, comprising a pre-operative regimen of a specialized immunonutrition supplement, a post-operative regimen of the supplement, and a monitoring system to track patient progress.

Novelty and Inventive Step

The inventive concept's novelty lies in its tailored approach to specific patient populations and operational environments, which is not addressed by the original patent. The inventive step is the combination of specialized immunonutrition supplements, packaging, and administration regimens that address the unique challenges of these environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include customized immunonutrition supplements for patients with specific medical conditions, such as heart disease or diabetes, or for patients undergoing other types of high-risk surgeries. Additionally, the inventive concept could be adapted for use in space exploration or military operations.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of surgical nutrition, disaster relief, and high-risk surgery. The target market includes hospitals, surgical centers, and disaster relief organizations.

Original Patent Information

Patent NumberUS 11,857,525
TitleTreatment or prevention of surgery-induced cachexia and/or expression of myeloid-derived suppressor cells and pro-inflammatory cytokines
Assignee(s)SOCIÉTÉ DES PRODUITS NESTLÉ S.A.